Literature DB >> 9247505

Pathologic correlates of aortic plaques, thrombi and mobile "aortic debris" imaged in vivo with transesophageal echocardiography.

P Vaduganathan1, A Ewton, S F Nagueh, D G Weilbaecher, H J Safi, W A Zoghbi.   

Abstract

OBJECTIVES: This study sought to evaluate the pathologic correlates of aortic atheromas, thrombi and mobile "aortic debris" imaged in vivo by transesophageal echocardiography (TEE).
BACKGROUND: Atherosclerotic plaques with various complexity, thrombi and debris are frequently identified by TEE during imaging of the aorta. However, pathologic data to characterize these lesions imaged in vivo are lacking.
METHODS: Intraoperative TEE was performed prospectively in 31 patients undergoing repair of aortic aneurysm or dissection. TEE was used to guide the surgeon to mark aortic areas of interest that were sent for pathologic examination. A four-point scoring system was used for both TEE and pathologic evaluation to grade the degree of involvement of the aortic wall with atheroma. Ultrasound video intensity of the aortic wall lesions was measured and compared with quantitative measures of wall composition at pathologic examination. The presence of thrombi and mobile aortic debris by TEE was noted and compared with pathologic findings.
RESULTS: Histologic-TEE correlations were possible in 62 aortic segments. There was 73% exact agreement between TEE and pathologic grading. Discrepancies were mostly in the inability of TEE to detect superficial ulcerations. However, separation of normal aorta and minimal intimal thickening (grades I and II) from more complex atheromas (grades III and IV) was observed in 93%. For identification of thrombus, TEE had a sensitivity of 91% (29 of 32 segments) and a specificity of 90% (27 of 30 segments). Mobile aortic debris were identified in six aortic segments and were confirmed at pathologic examination to be thrombi. Ultrasound video intensity increased with worsening complexity of atheroma and related significantly to aortic plaque composition at pathologic evaluation (r = 0.80, p < 0.0001). Ultrasound intensity of thrombi and mobile debris was similar and was lower than that of complex atheromas.
CONCLUSIONS: Thus, in the evaluation of aortic pathologic segments, TEE can assess aortic plaque complexity and identify thrombus formation, findings that may have important therapeutic implications.

Entities:  

Mesh:

Year:  1997        PMID: 9247505     DOI: 10.1016/s0735-1097(97)00181-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  7 in total

Review 1.  Transesophageal echocardiography and stroke.

Authors:  Timothy D Woods
Journal:  Curr Atheroscler Rep       Date:  2005-07       Impact factor: 5.113

Review 2.  Aortic atherosclerosis and embolic events.

Authors:  Muhamed Saric; Itzhak Kronzon
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

3.  Atheroembolism.

Authors:  John S. Smyth; John E. Scoble
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-06

4.  Aortic Source of Brain Embolism.

Authors:  Geoffrey A. Donnan; Stephen M. Davis; Elizabeth F. Jones; Pierre Amarenco
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-07

5.  Aortic atherosclerosis, hypercoagulability, and stroke the APRIS (Aortic Plaque and Risk of Ischemic Stroke) study.

Authors:  Marco R Di Tullio; Shunichi Homma; Zhezhen Jin; Ralph L Sacco
Journal:  J Am Coll Cardiol       Date:  2008-09-02       Impact factor: 24.094

Review 6.  The Evolving Role and Use of Echocardiography in the Evaluation of Cardiac Source of Embolism.

Authors:  Fabrizio Celeste; Manuela Muratori; Massimo Mapelli; Mauro Pepi
Journal:  J Cardiovasc Echogr       Date:  2017 Apr-Jun

7.  Aortogenic Embolic Stroke Diagnosed by a Pathological Examination of Endovascularly Removed Thrombus: An Autopsy Report.

Authors:  Genki Usui; Hirotsugu Hashimoto; Yoshiya Sugiura; Yuji Nishi; Masashi Kusakabe; Hajime Horiuchi; Seiji Okubo; Teppei Morikawa
Journal:  Intern Med       Date:  2019-06-07       Impact factor: 1.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.